Desmopressin
Desmopressin
CLINICAL USE
Diabetes insipidus Nocturnal enuresis Post-biopsy bleeding (unlicensed indication)Pre-biopsy prophylaxis (unlicensed indication)
DOSE IN NORMAL RENAL FUNCTION
Diabetes insipidus: Oral: 0.2–1.2 mg daily in 3 divided doses. IV: 1–4 mcg daily. Inhaled: 10–40 mcg in 1 or 2 divided doses. Sub-lingual: 120–720 mcg dailyNocturnal enuresis: Oral: 200–400 mcg at bedtime, Biopsy: Males – 16 mcg; Females – 12 mcg or 300–400 nanograms/kg Pre-biopsy prophylaxis in uraemic patients: 20 mcg (IV) over 30 minutes
PHARMACOKINETICS
Molecular weight                           :1069.2 %Protein binding                           :0 %Excreted unchanged in urine     : 45 Volume of distribution (L/kg)       :0.2–0.41half-life – normal/ESRD (hrs)      :Inhaled: 55 minutes; Oral: 2.8 hours; IV: 51–158 minutes/– DOSE IN RENAL IMPAIRMENT
GFR (mL/MIN)
20 to 50     : Dose as in normal renal function 10 to 20     : Dose as in normal renal function <10           : Dose as in normal renal function DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES
CAPD                :Unlikely to be dialysed. Dose as in normal renal function HD                     :Unlikely to be dialysed. Dose as in normal renal function HDF/high flux   :Unknown dialysability. Dose as in normal renal function CAV/VVHD      :Unlikely to be dialysed. Dose as in normal renal function IMPORTANT DRUG INTERACTIONS
Potentially hazardous interactions with other drugsNone known ADMINISTRATION
Reconstition
Dilute dose to 50 mL with sodium chloride 0.9% Route
IV, intranasally, oral, SC, IM, SL Rate of Administration
Over 20–60 minutes Comments
Do not inject at a faster rate – greater risk of tachyphylaxisIn patients with ischaemic heart disease, infuse more slowly – increased risk of acute ischaemic event OTHER INFORMATION
Emergency treatment of more generalised bleeding unresponsive to normal treatments: 0.1–0.5 micrograms/kg 4 times a day + IV conjugated oestrogens (premarin) 0.6 mg/kg/day for up to 5 days DDAVP works as a haemostatic by stimulating factor VIII production Onset of action less than 1 hour. Duration of effect 4–8 hours
See how to identify renal failure stages according to GFR calculation
See how to diagnose irreversible renal disease
Home